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Mass resolution: The resolution for a single peak of mass m is commonly
expressed as m/Dm, where Dm is the width of the peak at half its height
(FWHM) resolution. Masses differing by the mass resolution yield distinguish-
able peaks. For metabolites, the resolution can be around 100 000 in ultra-high
resolution mass spectrometers, which means that they can, in principle,
resolve millions of peaks (although the dynamic range of the instruments will
prevent such extreme performance).
Mass accuracy: Difference between measured and actual mass relative to the
actual mass. Using FTICR-MS or an Orbitrap mass analyzer this can be as low
as 1 part per million (ppm), which means that a mass of 100 Da is measured
accurately up to four decimal places.
Metabolite: Small biological molecule, usually with a mass below 1500 Da.
Typical examples are sugars, nucleotides, alkaloids and lipids.
Metabolomics: The comprehensive identification and quantification of all
metabolites and their relationships in a biological sample.
Molecular formula: The absolute number of atoms of each element that make
up a molecule. Mass spectrometry can not discriminate between molecules
that have the same molecular formula but different structure (isomers) unless
additional information (e.g. from chromatography or mass-spectrometric
fragmentation patterns) is used.The global study of the structure and dynamics of
metabolic networks has been hindered by a lack of
techniques that identify metabolites and their biochem-
ical relationship in complex mixtures. The recent appli-
cation of Fourier transform ion cyclotron resonance
mass spectrometry (FTICR-MS) to metabolomic analysis
suggests a way to tackle the problem. A lower-cost
alternative to high-field FTICR-MS, the Orbitrap mass
analyzer, promises accelerated activity in this area.
Here, we show how the ultra-high mass accuracy and
resolution provided by this new generation of mass
spectrometers can help to identify metabolites and
connect them into metabolic networks. Data from per-
turbation studies and isotope-tracking experiments
can complement this information to create metabolic
maps de novo and chart unexplored areas of met-
abolism.
The challenge of metabolomics
The study of metabolism is a founding discipline of
biochemistry. Researchers elucidated the structure of
central metabolic pathways in classical experiments and
began to determine cell-wide protein interaction networks
long before they sequenced whole genomes. In the post-
genome era, however, metabolomics (see Glossary) has
generally lagged behind its cousins: genomics, transcrip-
tomics and proteomics. In this article we will discuss how
recent developments in high-resolution mass spectrometry
(Fourier transform ion cyclotron resonance and Orbitrap
mass analyzers) could change this situation.
The immense chemical diversity of small biomolecules
makes comprehensive metabolome screens, comparable
to gene expression microarrays, difficult [1–3]. The lack of
unifying principles (such as the genetic code) that would
assist molecule identification, comparison and causal
connection is another important challenge. Hence,
although whole-genome information has been used to
infer the global metabolic network structure within
entire organisms, such efforts have been limited to
well-studied areas of metabolism. Moving beyond the
traditional biochemical map requires new experimental
approaches. Developing analytical methods that can
detect and quantify large numbers of metabolites (see
Glossary) in parallel was a necessary first step,
but a majority of all small molecules detected in aCorresponding author: Breitling, R. (r.breitling@rug.nl).
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www.sciencedirect.com 0167-7799/$ – see front matter  2006 Elsevier Ltd. All rights reservecellular sample remain unidentified. Furthermore, the
biochemical connectivity between such novel metabolites
has been impossible to assess. Even well known and
intensely studied biosynthetic pathways have proven
difficult to survey comprehensively. For example, the last
biosynthetic enzyme of mammalian cholesterol biosynth-
esis was identified only in 2002 [4]. Major parts of sec-
ondary metabolism, which determine important aspects
of the biological function and phenotype of an organism,
remain entirely unexplored.
Recent advances in ultra-high mass accuracy (see
Glossary) mass spectrometers (Box 1) could change this
situation. For some time, mass spectrometry has been the
technology of choice for resolving and quantifying complex
metabolite samples [5]. However, the identification of the
metabolites underlying the measured masses and, even
more so, their connection in metabolic networks was time-
consuming and impossible on a large scale. We argue that
twomajor advantages provided by the newultra-highmass
accuracy equipment can enable ab initio determination of
metabolic networks: (i) the ability to identify molecular
formulae (see Glossary) based on exact masses; and (ii) the
inference of biosynthetic relationships between masses
directly from the mass spectrum. Mass spectrometers with
the necessary performance parameters (mass accuracy
around 1 ppm and resolution above 100 000) are nowMonoisotopic mass: The mass of a molecule when all constituent atoms are of
the most common isotope. For small molecules this mass will give the largest
peak in a mass spectrum.
d. doi:10.1016/j.tibtech.2006.10.006
Box 1. Working principles of high-resolution mass spectrometers
Currently, two types of mass analyzer are able to achieve, routinely,
high-resolution andmass accuracy in the 1 ppm range for biomolecular
samples. In both instruments, the ionizedmetabolitemixture is trapped
in an orbital trajectory. The frequency of their orbit depends on the
mass-over-charge ratio of the ions and can be measured precisely,
which is the basis of the exceptional accuracy. In Fourier transform ion
cyclotron resonancemass spectrometry (FTICR-MS) [8,13], the trapping
is achieved in a strong magnetic field, which exerts a force on the
charged particles that is perpendicular to their direction of motion and
thus confines them to a circular path (Figure Ia). An additional electric
field contains the analytes in the direction parallel to themagnetic field.
Initially, the ions have low kinetic energy and thus orbit close to the
centre of the trap. They are excited by a radio pulse, which brings them
to a wider orbit and, at the same time, focuses them in a coherent
package. Because the ion packet now passes closely to the two
detection electrodes, it induces a sinusoidal image current that can be
measured. Because ions of multiple masses, and thus of different
orbital frequency, are present in the trap, the detected signal is a
superposition of multiple sinusoids, which are deconvoluted by fast
Fourier transform and converted from a frequency spectrum to a mass
spectrum. During the observation period, the excited ions travel a
distance of many kilometers on their orbit, which gives an intuitive
understanding of the physical basis for the potentially much higher
mass resolution (see Glossary) compared with time-of-flight mass
spectrometers [13]. Because the resolving power (and many other
figures of merit of FTICR-MS) are proportional to the strength of the
magnetic field [13], superconducting magnets (3–12 Tesla) are re-
quired, which makes the maintenance costs of FTICR-MS spectro-
meters relatively high. The Orbitrap is a recent alternative that traps
ions without a magnetic field [20,32], which is easier to maintain and
yields almost the same performance [9,12]. Here, ions are trapped in a
radial electric field between a central and an outer cylindrical electrode
(Figure Ib). As an ion packet enters the trap, the electric field is switched
on and attracts the ions to the central electrode. If the ions are
sufficiently fast, they will not plunge onto the electrode but remain on a
circular orbit around it, in the same way as planets are captured in their
orbit around central stars. In contrast to the FTICR-MS spectrometer,
the frequency on this circular orbit depends, in a complex way, on the
kinetic energy of the ions. To overcome this problem, the electrodes are
produced in a special spindle-shaped form, which modifies the electric
field in such a way that ions are attracted towards the equator of the
spindle. Ions injected off-centre will thus begin harmonic (pendulum)
oscillations around the equator, superimposed on their circular
motion. The frequency of this oscillation is proportional to the
mass-over-charge ratio and is detected and processed by fast Fourier
transform, as in FTICR-MS.
Figure I. Principles of ion cyclotron and Orbitrap ion traps. (a) In the ion
cyclotron, the ions are forced on a circular orbit, perpendicular to a strong
magnetic field, B, and are detected by measuring the induced image current in
two parallel electrodes in the y direction following excitation in the x direction.
The additional electric fields that contain the ions in the z direction and excite
them in the x direction are not shown. (b) In the Orbitrap, the ions are trapped in
a radial electric field and orbit around a central electrode. The superimposed
harmonic oscillations in the z direction are detected by measuring the image
current at the outer electrode.
544 Opinion TRENDS in Biotechnology Vol.24 No.12within the reach of many researchers and will change the
way we think about metabolomics.
Molecular identification
Molecules of the same nominal (integer) mass but different
molecular formulae will have slightly different exact
masses. For example, ethanol (C2H4O) and methyl hydra-
zine (CH4N2) bothhaveanominalmass of 44, but their exact
masses (44.026220 and 44.037449) differ by 0.011 Da
(225 ppm). If only the most common biological elements
are permitted (carbon, hydrogen, oxygen, nitrogen, sulfur,
and phosphate), only a finite number of combinations of
atoms will give a match to an observed mass with a given
degree of accuracy. In the case of metabolites, which are
smallmolecules by definition, it has been shown that amass
accuracy of 1 ppm will often enable an (almost) unique
assignment to a molecular formula [6,7] (Figure 1). Such
high accuracy is not routinely accessible by high-resolution
time-of-flight mass spectrometers, even using an internal
mass lock system,but canbeachievedby thenewgeneration
of mass analyzers (Box 1) [8–11]. Because the working
principle of these analyzers ensures that their mass accu-
racy increases with decreasing molecular weight [12,13],
they are particularly suitable for metabolomics. The identi-
fied formulae can then be used to search for correspondingwww.sciencedirect.commatches in databases of organic chemicals, such as
PubChem (http://pubchem.ncbi.nlm.nih.gov/) or the Dic-
tionary of Natural Products (http://www.chemnetbase.
com/scripts/dnpweb.exe). However, even at an accuracy of
1 ppm there are still limitations to this approach. For exam-
ple, even relatively small compounds suchasC2H8O2P2 (1,2-
ethanediylbis-phosphine oxide) and C3H2N4S ((1,3,4-thia-
diazol-2-ylamino)formonitrile) have monoisotopic masses
(see Glossary) of 125.99996 Da and 126.00002 Da, respec-
tively, and thus cannot be discriminated, even at 1 ppm
resolution [14]. For larger molecules, more and more
alternatives become chemically possible, although not
necessarily biologically plausible. Additional information
is required in those cases to assign possible structures.
Accurate measurement of the intensity ratio and
separation between isotope peaks provides another useful
level of information that can aid molecular identification.
Recent articles have shown that precise isotope ratios can
be almost as informative as ultra-high mass accuracy,
and only the combination of accurate isotope ratio and
mass information can lead to unique formula assign-
ments for many metabolites (particularly those between
300 and 1000 Da) [14–18]. Current FTICR-MS and
Orbitrap analyzers do not achieve accurate isotope ratio
Figure 1. Ultra-high accuracy and resolution are required to discriminate metabolites of near-identical mass. The masses of N-(2,4-dinitrophenyl)-2,4-dinitro-6-tert-butyl-
aniline (C16H15N5O8) (blue) and 11-(4-methylphenyl)sulfonyl-1,4,8-trithia-11-azacyclotetradecane (C17H27NO2S4) (green) differ by only 0.004 Da (1 ppm). This is one of the
most extreme cases observed in small-molecule databases. No other organic chemical has a similar mass; therefore, accurate mass measurement enables unambiguous
assignment of a molecular formula. If the resolution is also high enough (around 1 000 000 full-width half-maximum resolution), the two compounds could even be
distinguished in the same mixture.
Opinion TRENDS in Biotechnology Vol.24 No.12 545measurements (intensity accuracies of only 5–10% have
been reported [19]) but improvements in time-of-flight
mass spectrometers are showing great promise in this
area. However, the high resolving power of top-end FTICR
machines enables the discrimination of minor isotope
peaks, for example, a compound containing one 34S atom
can be resolved from a molecule containing two 13C atoms
[20]. This would enable the correct identification of
C2H8O2P2 and C3H2N4S, as described above (Figure 2).
Molecular connectivity
Isotope-distributionanalysis exploits relationshipsbetween
mass peaks to interpret spectra, and accurate mass infor-
mation enables still more extensive use of such relation-
ships. Metabolites in a biological sample are related: they
share biochemical ancestry and are linked within a closely
connected metabolic network. Within a metabolome, mole-
culeswill generally be related to precursors and derivatives.
Ultra-high mass accuracy also implies ultra-high mass
difference accuracy. Accurate mass differences, in turn,
contain information about chemical relationships between
molecules. A limited repertoire of chemical transformations
account for the majority of biochemical reactions within
cells. For example, hydrogenation–dehydrogenation (mass
difference +/ H2 = 2.01565 Da), oxidation (mass difference
www.sciencedirect.comO = 15.9949 Da) and phosphorylation (mass difference PO3
H = 79.9663 Da) are typical common reactions. A more
complex case is provided by condensation reactions, with
a mass difference H2O = 18.01055 compared to the sum of
the two precursor masses. Detecting a difference corre-
sponding to a common transformation between two meta-
bolites implies that they are likely to be chemically related
and might well be connected directly by an enzymatic reac-
tion. A systematic screen for commonly occurring mass
differences (metabolic-difference analysis) can create a
comprehensivemetabolitemap of a sample (Figure 3). Such
an approach is not new in mass spectrometry. Difference
analysis iswidelyused in the interpretation of tandemmass
spectra, where ‘neutral losses’ are identified and used to
infer, for example, the sequence of a fragmented peptide.
Metabolic-difference analysis is particularly powerful for
analyzing homologous series of compounds and has recently
been used to interpret the pattern of membrane phospho-
lipids in the protozoan Trypanosoma brucei, a parasite that
causes sleeping sickness [7] (Box 2). A similar approach
was followed to analyze a series of homologous hydro-
carbons in complex petrochemical samples [21]. In both
cases, the ultra-high accuracy provided by FTICR-MS
was necessary for the successful identification of
intermolecular relationships.
Figure 2. Isotopomers, including those of minority abundance, are resolved by ultra-high mass resolution. The theoretical spectrum of C2H8O2P2 (green) and C3H2N4S
(blue) is plotted at a mass resolution of 100 000 full-width half-maximum (FWHM). The two compounds have almost identical mass (Dm = 0.48 ppm) but can be clearly
separated by their isotope patterns, if the resolution and accuracy is high. This can be seen in the inset, which focuses on isotopomers with one additional neutron.
Moderately high resolution (10 000 FWHM), which can be achieved with time-of-flight mass spectrometers, does not discriminate the minor isotope peaks.
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The study of metabolite fragmentation by tandem mass
spectrometry can confirm and complement inferences
based on metabolic-difference analysis. For example, a
molecule of mass 785.59348 Da that is related to other
masses by the addition and loss of C2H4 units, as well as by
various dehydrogenation reactions, could be predicted with
good confidence to be dioleoylphosphatidylcholine. If the
fragmentation pattern in a tandemmass spectrum shows a
signal for the choline headgroup as well as loss of an oleic
acid side chain, this identification would be confirmed.
Both FTICR-MS and Orbitrap mass analyzers are avail-
able in hybrid instruments with linear ion traps, which can
make such a tandem strategy straightforward. FTICR-MS
has the additional benefit of being able to select the ion for
tandem spectrometry with high resolution in the ion cyclo-
tron resonance cell and fragment it inside the cell, which
has obvious advantages in a complex metabolomic sample.
Sample preparation, pre-processing and ionization all
lead to a bias towards specific classes of chemicals, so that
the final mass spectrum of a given sample will not repre-
sent the complete metabolome. Although this makes ‘one-
shot’ metabolomic resolution unlikely, it does actually offer
advantages. Biochemically connected compounds tend to
be chemometrically similar [22]; therefore, theywill tend to
occur together in the spectrum derived from a particular
sample preparation method. This information can be used
to assist in molecular identification and to place molecules
in a functional framework.www.sciencedirect.comMetabolic difference analysis can also be combined
with perturbation experiments, which monitor the corre-
lation patterns of metabolites after external or internal
changes to the system [23,24]. Combining this with iso-
tope tracer studies, which follow the fate of metabolites
that are labelled with stable isotopes [25,26], is also an
obvious option to yield networks of chemically related
metabolites. The prospect of implementing pulse-chase
experiments to follow the fate of metabolic precursors in
time is appealing. The additional knowledge about
potential biochemical connections that is provided by
ultra-high mass accuracy will constrain the possible
interpretations of the spectra, enabling the analysis to
be extended to areas where little or no previous pathway
information exists. Shared correlation behaviour or iso-
tope dynamics will also serve to distinguish true and false
positive connections in the biochemical network, inferred
from the mass spectra.
Ultimately, a systematic use of the multitude of
parameters involved in sample preparation and analysis
can assist inmetabolite identification. Computational tools
for the automatic integration of the various levels of
information will provide great assistance in metabolome
exploration.
Remaining challenges
Theoretically, the resolving power of the FTICR-MS and
Orbitrap is sufficiently high to resolve even the most
complex metabolite mixtures using direct infusion. This
Box 2. Case studies
The number of metabolomics studies using ultra-high resolution
mass spectrometry is currently limited. A first proof-of-principle
study examined the metabolite composition of ripening strawber-
ries and transgenic tobacco flowers by direct injection FTICR-MS,
without previous separation [33]. Studies on Arabidopsis thaliana
(thale cress) metabolism followed [34–36]. In a recent paper, the
same technology was applied to the metabolome of the sleeping
sickness parasite Trypanosoma brucei and its host environment [7].
In the trypanosome study, metabolite mass differences were
measured with high precision and used successfully to confirm
metabolite identification and to predict biochemical relationships
between masses. Other FTICR-MS studies have focused on
particular metabolite species, for example, phospholipid profiles
of mouse brain, heart and liver [37]. Studies using Orbitrap
analyzers in comprehensive metabolomics experiments have still
to be published but initial reports using standard mixtures of small
molecules show promising performance parameters, with mass
accuracy around 2 ppm [12]. Accurate Orbitrap measurements
combined with tandem mass spectrometry have been used
successfully for sphingolipid profiling in yeast [27] and for tracking
the metabolic fate of anti-depressant drugs in human liver micro-
some preparations [38]. In the latter case, the combination of
accurate mass analysis, fragmentation patterns and predictive
metabolite identification software enabled the reconstruction of
biotransformation pathways with high confidence.
Figure 3. Mass differences of metabolites help the inference of metabolic
relationships. (a) High-resolution mass spectrum of the Trypanosoma brucei
metabolome, focusing on the mass range containing phospholipids. Mass
809.5935 is a phosphatidylcholine with 38 side-chain carbons and 4 unsaturated
bonds (a possible formula is shown on top). It is related to other metabolites in the
sample by characteristic accurate mass differences. (b) Knowledge of the exact
mass differences identifies the related metabolites and places them in a fully
connected metabolic network, of which only a small part is shown here.
(c) Average abundances for all members of the phosphatidylcholine series.
Longer side-chains contain larger numbers of unsaturated bonds. Patterns like this
only become obvious when the data are organized on the basis of exact mass
information.
Opinion TRENDS in Biotechnology Vol.24 No.12 547can lead to rapid experimentation and minimizes bias
introduced during pre-processing. However, such a direct
infusion approach has important practical limitations, and
a pre-separation step can be useful for several reasons.
First, it provides an additional dimension of information
(retention time) that can help the identification of mole-
cules and separation of isomers. Molecules with the same
mass but distinct structures and physiological functionwww.sciencedirect.com(e.g. glucose-1-phosphate, glucose-6-phosphate and
fructose-6-phosphate) can only be discriminated and quan-
tified when such additional information is available; even
then, discrimination of stereoisomers can be difficult. Sec-
ond, molecules frequently compete during the ionization
step, so that the presence of one compound in high abun-
dance or with a high ionization potential can strongly
repress the signal of another (ion suppression), which
substantially interferes with quantification. Such effects
are reduced if the ionized mixture is less complex. Finally,
pre-separation can increase the dynamic range of the
analysis. Only a limited number of ions can be analyzed
at the same time inside an ion trap because molecular
crowding leads to interactions between the ions (space–
charge effects) that distort the signal and substantially
reduce mass accuracy. This is particularly the case for
FTICR-MS, where all ions share the same orbit and, in
extreme cases, mass errors in excess of 10 ppm can
result. A pre-separation step spreads the spectrum over
a larger number of scans and enables optimal ion
accumulation at each time point. Both FTICR-MS and
Orbitrap mass analyzers can be coupled to many different
ion sources – including (nano)electro spray, atmospheric
pressure chemical, and matrix-assisted laser desorption
ionization – and various pre-separation protocols – liquid
chromatography, gas chromatography or capillary electro-
phoresis. This is facilitated by hybrid mass spectrometers
that couple the high-resolution mass analyzer to a pre-
ceding quadrupole or ion trap [12,27–29], where ions are
accumulated, selected and potentially fragmented before
analysis. Such a setup also enables automatic gain control,
which minimizes space–charge effects and leads to
concentration-independent accuracy throughout a wide
dynamic range [10]. Optimizing the pre-processing steps
(including the challenging sample preparation [5]) to
ensure maximally unbiased transfer of metabolites to
the mass analyzer will be crucial for further advances.
548 Opinion TRENDS in Biotechnology Vol.24 No.12Another major challenge is posed by data processing
and analysis. The higher the resolution, the larger the data
files that need to be analyzed. If additional dimensions are
added by chromatographic pre-separation and tandem
mass spectra, the task rapidly becomes daunting. New
bioinformatics techniques need to be developed to auto-
mate and optimize both the data acquisition and the
interpretation processes, to make routine high-throughput
applications at the highest resolution possible. The first
steps in this direction have recently been published [30,31].
The ultra-high resolution provided by the new
generation of mass spectrometers promises that the
resulting spectra will lead to exciting new discoveries in
territories of the metabolic map that have, up to now, been
inaccessible.
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